×

Research and Markets: DRG Insight: Hypertension (G7)

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/7bf76r/drg_insight) has announced the addition of Decision Resources, Inc's new report "DRG Insight: Hypertension (G7)" to their offering.

DRG Insights takes the most relevant information and insights from across our portfolio for BioPharma and Med-Tech products and delivers the insight heavy perspective that you need to generate better ideas and deliver more successful campaigns and initiatives.

The hypertension market, though mature and heavily genericized, offers significant opportunities for blood pressure (BP)-lowering drugs that can prevent the development of cardiovascular disease, cerebrovascular disease, or end-organ damage.

The best on-market single-agent therapies achieve only relatively modest levels of BP reduction, hence the increasing prominence of fixed-dose combination (FDC) drugs in the market. However, physicians value the ability to titrate drug therapy, and payers are increasingly rewarding innovation and novel modes of therapeutic action, which signals room for new antihypertensive agents.

For existing and emerging therapies alike, the high disease prevalence, ease of diagnosis, and recognized need to treat hypertension also translates to substantial sales potential, even for therapies that capture a small share of the market.

Key Topics Covered:

Executive Summary

Current Market Landscape

Etiology & Pathophysiology

Staging/Patient Segmentation

Select Drug Targets

Growth Drivers & Constraints

Key Metrics

Population Dynamics

Market Landscape

Current Therapies

Treatment Algorithms

Country Specific Decision Trees

Comparison of Key Agents

Expert Insight on Prescribing Trends

Importance of Drug Attributes in Prescribing Decisions

Pricing & Reimbursement

Factors Influencing Pharmacy Director Tier Placement Decisions

Accessibility and Cost Hurdles

Reimbursement Environment

Unmet Needs

Emerging Therapies

Near-term Outlook

Long-term Outlook

Important Endpoints in Prescribing Decisions

Timelines

2010 and 2010 sales and Market Share

For more information visit http://www.researchandmarkets.com/research/7bf76r/drg_insight

Source: Decision Resources, Inc

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices, Pharmaceuticals

Source: Research and Markets